Covid

Monday

Dr Mark Toshner

Europe’s vaccine suspensions could come back to bite Britain

Germany is the latest country to suspend the Oxford-AstraZeneca coronavirus vaccine over concerns about possible side effects. The Netherlands and Ireland have taken similar steps. So too has Denmark, Norway, Bulgaria and Iceland, while Italy and Austria have halted the use of certain batches of the drug as a precautionary measure.  Britain has done many things wrong in its handling of the pandemic, but it has done one thing well: the rollout of the jab. It's the one place where we have useful lessons to teach the world in Covid-19. Europe, in particular, does not appear to be listening. Vaccine programmes as ambitious as the one needed now require joined-up international co-ordination and action.

Saturday

Bruno Macaes

After Covid, get ready for the Great Acceleration

Before the pandemic struck, there was talk of a ‘Great Stagnation’ – the idea that the world economy was doomed to lacklustre growth and had hit a technological plateau with no game-changers in sight. But Covid - and lockdown - has changed all that. There was such doubt about the vaccines because it normally takes at least ten years to develop a successful immunisation. Now, we have six working ones. The innovation will not stop there: breakthroughs are happening at rapid speed, from transport and energy, to medicine and science, and even when it comes to currencies. Take transportation and energy. Last October, for example, Waymo finally announced the launch of a taxi service that is fully driverless and open to the public.

Tuesday

Jake Wallis Simons

Corruption affects everything in Palestine – even vaccines

Visit certain parts of the West Bank and you’ll encounter mansions owned by senior officials in the Palestinian Authority (PA). By any standards – let alone those to which ordinary citizens are accustomed – they are impressive, with arches, colonnades and tall windows. If you’d been watching them in recent weeks, you might have seen vaccines being quietly delivered to these residences in unmarked cars, having been skimmed off the supply intended for medical workers. Those, at least, were the allegations made by a number of Palestinian human rights and civil society groups. Last week, the Palestinian health ministry was forced to come clean.

Monday

Isabel Hardman

Will reopening schools set back Boris’s lockdown timetable?

Schools in England have gone back today, with pupils taking lateral flow tests and being asked to wear masks in order to keep the risk of infections as low as possible.  Today Boris Johnson held a special press conference to mark what he described as an 'emotional' moment in the exit from lockdown. He said that the 'overwhelming feeling is one of relief' and that the 'greater risk now is keeping them out of school for a day longer'.  There are rumblings about whether the current plan for lifting restrictions is sustainable He praised teachers for getting schools ready and for teaching throughout the lockdown period, and parents for homeschooling while trying to hold down their own jobs.

Friday

Mary Dejevsky

Why NHS workers shouldn’t get a pay rise

The Government in the person of Rishi Sunak won a surprisingly positive public response to what was essentially a tax-raising Budget this week. Within 24 hours though, the same government had spectacularly lost the PR contest by recommending a 1 per cent pay rise for NHS staff across the board. The outcry was universal: mean, measly, an insult, a slap in the face, not a way to treat ‘our heroes’ – or, more personally, those who saved the Prime Minister’s life. The rise – and it is currently just a recommendation to the NHS pay review body – is indeed a mistake. In fact, it is a double mistake, but not in the way it is being presented. The first error is diplomatic and tactical.

Ross Clark

Covid-19 and the problem with Britain’s weight

How strong is the link between obesity and the danger of dying from Covid? Yesterday, the World Obesity Federation published a report containing a widely-quoted statistic that 2.2 million out of 2.5 million Covid deaths globally have occurred in countries where more than half the population is overweight. The figure is stark, although also highly unsatisfactory. Obesity tends to be more prevalent in wealthy countries – which also happen to have more aged populations, another strong risk factor in Covid deaths. Yet the report also collates a substantial body of evidence linking obesity more directly with Covid deaths.

Thursday

Matthew Lynn

The EU’s ugly vaccine nationalism

We have to rid the world of vaccine nationalism. No one is protected until we are all protected. And we need, above all, solidarity to fight a virus which by its nature does not respect borders or boundaries. Over much of the last year, European Union officials, led by the President of the Commission Ursula von der Leyen, have led the world in grandiose rhetoric about how we have to lead a global effort to fight Covid-19, contrasting its own noble internationalism with the grubby self-interest of the likes of Donald Trump or indeed Boris Johnson. But hold on. After much speculation, the EU has itself started firing the first shots in the vaccine wars, permitting Italy to block the export of 250,000 doses of the Oxford-AstraZeneca jab to Australia.

Ross Clark

Is the fall in Covid infections really slowing down?

Imperial College’s REACT study is given a prominence over other Covid data, but it is a struggle to understand why. This morning, as so often, BBC news bulletins included the latest tranche of results from the study, suggesting that the fall in new Covid infections is ‘slowing'.  The data appears to confirm a deceleration in the fall in infections that was evident in the Test and Trace figures a fortnight ago – and which I wrote about here a week ago – but which has since been reversed. React seems to be telling us a story which we could equally glean much earlier from the PHE figures.

Julian W Tang

Why we shouldn’t worry about Covid super strains

Should we worry about new Covid variants? Much has been made in recent weeks about the potential for new Covid strains to arise, and the danger of a new super variant bypassing all our vaccines and bodies’ existing defences to cause another global pandemic even worse than this one. But while I would say that this is not impossible and could happen, it would be very unusual if this took place. We know from previous epidemics what happens when a population encounters a new virus. When Europeans first discovered South America, the viral infections they imported – measles, chickenpox, smallpox, influenza – killed more of the indigenous people than any of the related wars taking place.

Wednesday

Robin Aitken

Is the news making us unwell?

Since the start of the pandemic I’ve been observing friends and family and their reactions to the virus. Broadly speaking they fall into two groups; at one end of the spectrum there are the insouciant, apparently unconcerned about a viral threat they think has been exaggerated; at the other are the corona-obsessives who have avidly consumed every scrap of information they can find – of which there has been no shortage. They’ve become minutely informed on everything from T-cells to lateral-flow tests; their lives have been subsumed under a tsunami of technical information. Of the two groups it is the wilfully ignorant who seem happier.

Tuesday

William Nattrass

Covid is tearing the Czech Republic apart

The Covid-19 situation is rapidly deteriorating in the Czech Republic, with new efforts to stop the spread of the virus descending into bitter rows and a climate of cynicism and fear. In a government press conference held late on Friday night, harsher measures were announced to tackle the alarming spread of the ‘British variant’ of coronavirus in the Czech Republic. These restrictions included the closure of more shops and services, the closing of primary schools and nurseries, the reintroduction of mandatory face mask wearing outside, and a ban on movement between municipalities. Cases and deaths have risen to new heights in recent weeks, leaving Czech hospitals on the verge of collapse.

Steerpike

The New York Times’ orgy of British despair

The New York Times seems to have developed a strange view of Britain in recent years – or at least since the Brexit vote in 2016. In the NYT’s world, the UK is a desolate place, where locals huddle round bin fires on the streets of London, gnawing on legs of mutton and cavorting in swamps during the summer, ever fearful of the despot Prime Minister, Boris Johnson. So Mr S was not exactly surprised to see that the paper’s latest missive from the Covid frontline in Britain, published today, veered on the negative side, detailing the ‘crushing onslaught of a pandemic’ in hospitals, in what can only be described as an orgy of British despair.

Monday

Isabel Hardman

Is Gavin Williamson doing enough for deprived children?

There are just days until all pupils return to English schools, and Conservative MPs are becoming increasingly concerned about what state many of these students will be in when they arrive back in the classroom after the best part of a year trying to learn from home. At today's Education Questions in the House of Commons, a number of backbenchers pressed Education Secretary Gavin Williamson on the work the government is doing to get the most disadvantaged children back up to speed. Both Jack Brereton and Julian Sturdy had tabled questions asking 'what support his department is providing to help children catch up on lost learning during the Covid-19 outbreak'. Williamson's response was to point to the £1.

Cindy Yu

The West’s vaccine complacency

On Monday, in their first bilateral summit, Joe Biden will meet (virtually) Mexico’s President Andres Manuel Lopez Obrador. Among other things on the agenda, Lopez Obrador is expected to ask Biden to share America’s vaccines with his country. With 186,000 deaths, Mexico has one of the world’s highest Covid-19 death tolls and it desperately needs these jabs. After Mexico’s Pfizer supply dried up, it has had to rely on Russia’s Sputnik V vaccine, as well as China’s Sinovac and CanSino (which was developed by the Chinese military). Could America relieve this pressure? It doesn’t appear so.

James Forsyth

Oxford’s remarkable vaccine success

It is worth taking a moment to stand back and applaud Sarah Gilbert and the Oxford vaccine team’s achievement. The data released this evening by Public Health England shows that a single dose of both the Oxford /AstraZeneca vaccine and the Pfizer vaccine cuts the risk of hospitalisation by 80 per cent in the over-80s, the most vulnerable group. It also suggests that the Oxford one, despite its messy trial data, is slightly more effective than the Pfizer vaccine in preventing symptomatic infection among the over-70s. The efficacy of the Oxford vaccine has completely changed the outlook for the UK.

Katy Balls

The UK’s Covid strategy gets a vaccine boost

Matt Hancock had good news for today's press conference: the Health Secretary said the effectiveness of vaccines was beginning to show in the data. While hospitalisations are falling across the board, they are falling the fastest among the priority groups that have received the vaccine. Deputy Chief Medical officer Jonathan Van-Tam said that both the Oxford/AstraZeneca and Pfizer vaccine are reducing hospitalisations by 80 per cent in the over-70s. Hancock said that the most recent data showed that protection from the Oxford vaccine after 35 days is even greater than Pfizer – though both vaccines produce an 80 per cent reduction in hospitalisations.

Matthew Lynn

Can the EU be trusted to introduce vaccine passports?

The contracts were badly drafted. The orders were late. Too few resources were made available for the scale of the task, and the regulators dithered and delayed. Even the most fanatical federalists such as Guy Verhofstadt have admitted the EU’s vaccine programme was little short of a catastrophe. But hey, what does that matter? Ursula von der Leyen has decided this is the moment to double down on the EU’s Covid-19 strategy, and launch a centralised vaccine passport. What could possibly go wrong? Well, er, as the EU’s vaccine fiasco has taught us, lots actually. Von der Leyen has today tried to bounce back from her difficulties with the vaccine programme with a plan for EU-wide Covid passports.

Sunday

Jack Shamash

The battle for the soul of the Jewish community

There are two groups in the Jewish community – mainstream Jews who, while still religious, do their best to assimilate into the wider community and the Chareidi, ultra-orthodox Jews who tend to shun British society. Those two groups are now locked in a struggle for the future of the Jewish community. For over 100 years, the Chareidi – with their distinctive costume, based on the fashions of 18th century Poland – have had a sort of symbiotic relationship with the mainstream. If mainstream Jews needed kosher slaughterers, rabbinical judgements, circumcisions and even rabbis for the smaller pulpits, they relied on the Chareidi. They were the ones with an encyclopaedic knowledge of Jewish law.

Friday

Joanna Rossiter

What Angela Merkel can learn from the Queen about vaccine scepticism

You have to feel for Germany. After a fraught vaccine procurement process, not only is the government struggling to persuade its citizens to take the Oxford AstraZeneca vaccine, but Angela Merkel has now stated that she will not be given the jab on account of her age.  ‘I do not belong to the recommended age group for AstraZeneca,’ the German chancellor told Frankfurter Allgemeine Zeitung newspaper. It could well be the final nail in the coffin for an EMA-approved, safe vaccine that has cost her country millions. Merkel’s view may be aligned with government policy – she is 66 and therefore, under the German rules which state that over 65s should not be given the vaccine, she does not qualify for a dose.

Thursday

Ross Clark

Why do old people have fewer antibodies after the vaccine?

The UK policy of delaying second doses of the Pfizer vaccine has been criticised by some as risky, with Pfizer warning that there is no data on the effectiveness of its vaccine other than for the dosing regime used in phase 3 trials: two doses, 21 days apart. But evidence is steadily trickling through. Earlier in the week I wrote here about the Scottish population-wide study which found that a single dose of the Pfizer vaccine reduced hospital admissions by 85 per cent between 28 and 34 days after the jab. This morning comes Imperial College’s React-2 study, which paints a picture that is, on the face of it, rather less flattering. It tested 154,000 people for the presence of antibodies to SARS-CoV-2, the virus which causes Covid-19.